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jun-N-terminal kinase regulates thrombin-induced PAI-1 gene
expression in proximal tubular epithelial cells.
Background. Interstitial activation of the coagulation cas-
cade is a common finding in acute and chronic tubulointersti-
tial damage. We previously demonstrated that thrombin may
induce proximal tubular epithelial cells (PTEC) proliferation
and regulate, through plasminogen activator inhibitor (PAI)-1
and urokinase-type plasminogen activator (u-PA), their profi-
brotic activity. The signaling pathways leading to these effects
are still unknown. The PAI-1 promoter contains several acti-
vator protein-1 (AP-1) consensus sequences. AP-1 activation
is induced by different agonists through jun-N-terminal kinase
(JNK). Thus, we investigated the role of the JNK-AP-1 axis on
thrombin-induced PAI-1 and u-PA expression in immortalized
PTEC and its modulation by PKC and src, two key signaling
enzymes.
Methods. JNK and src activation was investigated by West-
ern blotting, PAR-1 cellular surface expression by flow cytom-
etry, PAI-1 and u-PA gene expression by Northern blotting,
AP-1 activation by transient transfection, and DNA synthesis
by 3H-thymidine uptake.
Results. Thrombin and PMA induced a time-dependent in-
crease of JNK phosphorylation in immortalized PTEC that was
inhibited by PKC down-regulation. Both thrombin and PMA
caused AP-1 activation, significantly reduced by src inhibition.
Phorbol 12-myristate 13-acetate (PMA), indeed, induced an
increase in src phosphorylation. Both PMA- and thrombin-
stimulated PAI-1 gene expression was abolished by JNK,
protein kinase C (PKC), and src inhibition, and this effect
was regulated at the trascriptional level. PKC, but not src or
JNK inhibition, abolished thrombin-elicited u-PA expression.
Finally, JNK inhibition did not influence thrombin-induced
proliferation.
Conclusion. Our data suggest that thrombin activates the
JNK-AP-1 axis in a PKC- and src-dependent manner in PTEC.
This axis, necessary for thrombin-stimulated PAI-1 expression,
but not for its fibrinolytic and regenerative effect, may repre-
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sent a therapeutic target in acute and chronic tubulointerstitial
damage.
Interstitial fibrin deposition is a common histologic
finding in several renal diseases characterized by tubu-
lar and/or interstitial damage, including obstructive
nephropathy, experimental lupus nephritis, ischemic
tubular necrosis, and acute as well as chronic renal al-
lograft rejection [1–6]. This observation indirectly sug-
gests the release of thrombin within the interstitial space.
This serine protease may be accumulated in its active
form within the fibrin clots and released locally over a
long period of time. In the interstitium, thrombin can
interact with its specific cell surface receptors and modu-
late a variety of cell functions [7–8]. Indeed, tubular cells
in normal kidney express the main thrombin receptor,
protease-activated receptor 1 (PAR-1) [9]. In addition,
we have recently reported a significantly increased tubu-
lar expression of this receptor in renal biopsies of patients
affected by chronic allograft nephropathy associated with
an augmented fibrin deposition [10].
PAR-1 belongs to the G protein–coupled receptor su-
perfamily, and its partial proteolysis by thrombin results
in phospholipase C activation, leading to an increase in
intracellular calcium and diacylglycerol [11]. These early
events may turn on PKC, a key enzyme in the regulation
of several cell functions, including cell proliferation and
growth factor expression [12]. There is an increasing body
of evidence that PAR-1 proteolysis may also induce cyto-
plasmic tyrosine kinase activation in several cell lines [13,
14]. In particular, thrombin can modulate src activity in
proximal tubular epithelial cells (PTEC), and this cyto-
plasmic kinase plays a pivotal role in thrombin-induced
proinflammatory and regenerative effects [9].
A significant pathogenic role for thrombin-PAR-1 in-
teraction in the development of the interstitial changes
featuring acute and chronic renal diseases is suggested
by the ability of this coagulation factor to induce the
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expression of several proinflammatory and profibrotic cy-
tokines [9–10, 15–16]. Among the profibrotic factors, plas-
minogen activator-inhibitor-1 (PAI-1) represents one of
the main targets for thrombin action [16]. This antifibri-
nolytic peptide plays a key role in extracellular matrix de-
position, significantly reducing its turnover [17, 18]. PAI-1
gene expression is strikingly induced in several chronic
tubulointerstitial diseases characterized by progressive
interstitial fibrosis [4, 5, 10]. Interestingly, we reported
that in chronic allograft nephropathy, its renal mRNA
levels are significantly correlated with PAR-1 tubular ex-
pression [10]. Noteworthy, its profibrinolytic counterpart,
u-PA, is equally induced by thrombin, although very lit-
tle is known on the signaling pathways regulating these
divergent effects of the coagulation factor [19].
PAI-1 promoter region contains several activator
protein-1 (AP-1) consensus sequences, and the activation
of this transcription factor has been suggested to modu-
late PAI-1 gene expression [20, 21]. The dimerization of
jun and fos to form AP-1 can be induced by several ag-
onists through jun-N-terminal kinase (JNK) activation
[22, 23]. JNK belong to the mitogen-activated protein ki-
nases (MAPKs) and is stimulated by cellular stresses such
as heat shock, osmotic shock, and ultraviolet irradiation,
and by an array of inflammatory cytokines, including tu-
mor necrosis factor-a and interleukin-1 [22]. Recent stud-
ies have demonstrated that different G protein–coupled
receptor agonists, including carbachol and angiotensin
II, activate JNK in several cell lines [24, 25]. Thus, in
the present study, we investigated the role of the JNK-
AP-1 axis on thrombin-induced PAI-1 gene expression
in PTEC and its modulation by PKC and src.
METHODS
Reagents
Dulbecco’s modified Eagle’s medium (DMEM)/F12
medium and fetal bovine serum (FBS), insulin, trans-
ferrin, T3, hydrocortisone, prostaglandin E1, trypsin,
and selenium were obtained from Sigma Cell Culture
(Milan, Italy). Penicillin/streptomycin and L-glutamine
were obtained from Life Technologies (Milan, Italy).
PP3 was from Calbiochem (San Diego, CA, USA). PP1
was from Biolmol (Plymouth Meeting, PA, USA). Bovin
thrombin, phorbol-12-myristate-13-acetate (PMA), cur-
cumin, leupeptin, and actinomycin D were from Sigma
Chemical Co. (Milan, Italy). SP600125 and H7 were
from Alexis (Lausen, Switzerland). The pLuc3XAP-1
vector (containing the firefly luciferase cDNA under the
control of three AP-1 consensus sequences) [26] was
kindly provided by Dr. C. Glass (University of Southern
California at San Diego). The dual luciferase assay kit
was from Promega (Milan, Italy). The monoclonal an-
tiphosphotyrosine antibody Py20 was obtained from Up-
state Biotechnology, Inc. (Lake Placid, NY, USA). The
polyclonal anti c-Src pp60 rabbit antibody was pur-
chased from Santa Cruz Biotechnology, Inc. (Santa Cruz,
CA, USA). The polyclonal anti-Src pY418 rabbit anti-
body was purchased from BioSource International, Inc.
(Camarillo, CA, USA). The polyclonal anti-JNK1 rab-
bit antibody was purchased from Santa Cruz Biotech-
nology, Inc. The monoclonal anti-pJNK mouse antibody
was purchased from Santa Cruz Biotechnology, Inc. The
horseradish-peroxidase (HRP)-conjugated sheep anti-
mouse and sheep antirabbit antibodies were supplied
from ECL (Amersham Biosciences, Buckinghamshire,
UK). [32P]dCTP and [methyl-3H]-thymidine were pur-
chased from ICN (Milan, Italy) and Amersham Bio-
sciences, respectively. All other chemicals were reagent
grade.
Cell isolation and culture
HK2, an immortalized PTEC line from normal adult
human kidney [27], was obtained from American Type
Culture Collection (ATCC, Manassas, VA, USA). Cells
were grown to confluence in DMEM/F12 medium sup-
plemented with 10% FBS, 100 U/mL penicillin, 100 lg/
mL streptomycin, 2 mmol/L L-glutamine, 5 lg/mL in-
sulin, 5 lg/mL transferrin, 5 ng/mL sodium selenite,
5 pg/mL T3, 5 ng/mL hydrocortisone, and 5 pg/mL
prostaglandin E1. For passage, confluent cells were
washed with phosphate-buffered saline (PBS) 1×, re-
moved with 0.05% trypsin/0.02% ethylenediamine-tetra-
acetic acid (EDTA) in PBS, and plated in DMEM/F12.
Western blot
HK2 were plated in 6-well dishes and grown to conflu-
ence in DMEM/F12 supplemented with 10% FBS. The
cells were incubated 40 hours in serum-free medium,
and then exposed to thrombin (5 U/mL) for the indi-
cated time periods. At the end of the treatment, the cell
monolayer was rapidly rinsed twice with ice-cold PBS and
lysed in 100 lL of RIPA buffer [1 mmol/L phenylmethyl-
sulphonylfluoride (PMSF), 5 mmol/L EDTA, 1 mmol/L
sodium orthovanadate, 150 mmol/L sodium chloride,
8 lg/mL leupeptin, 1.5% Nonidet P-40, 20 mmol/L Tris-
HCl, pH 7.4]. The lysates were kept on ice for 30 min-
utes and centrifuged at 10,000g at 4◦C for 5 minutes.
The supernatants were collected and stored at −80◦C
until used. Aliquots containing 40 lg of proteins from
each lysate were subjected to sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE) on a
10% gel under reducing conditions and then electro-
transferred onto nitrocellulose membrane (HybondTM C;
Amersham, UK). The filter was blocked for two days at
room temperature (RT) with 2% bovine serum albumin
in PBS containing 0.1% Tween-20 (TBS), and incubated
with monoclonal antiphospho-JNK (Santa Cruz Biotech-
nology) or antiphospho-Y418-src antibodies (BioSoure)
Pontrelli et al: Thrombin profibrotic signaling in proximal tubular epithelial cells 2251
at 1:500 dilution in TBS at 37◦C for 2 hours. The mem-
branes were washed twice in TBS and incubated for one
hour at RT with HRP-conjugated sheep antimouse im-
munoglobulin (Ig)G at 1:1500 dilution in TBS. The mem-
branes were washed three times at RT in TBS, and then
once with 0.1% SDS in PBS. The ECL-enhanced chemi-
luminescence system (Amersham, UK) was used for de-
tection. The same membranes were then stripped and
immunoblotted again with antihuman JNK or src poly-
clonal antibody at 1:1000 dilution in TBS (Santa Cruz
Biotechnology) at 37◦C for 2 hours. The ECL-enhanced
chemiluminescence system (Amersham, UK) was used
for detection.
Flow cytometry
To determine the effect of prolonged exposure to PMA
on PAR-1 receptors available for thrombin binding, HK2
cells incubated in the presence or in the absence of PMA
(100 nmol/L) for 48 hours were used for flow cytometry.
Cells (300,000/condition) were resuspended in 0.1 mL
buffer (PBS + 0.1% BSA + 0.02% sodium azide) and
incubated with 5 lL of the PAR-1 antibody (Research
Diagnostic, Flanders, NJ, USA) for 30 minutes at 4◦C,
and with 5 lL of the fluorescein isothiocyanate (FITC)-
conjugated goat antimouse IgG F(ab)2 Ab (ICN/Cappel,
Aurora, OH, USA) for another 30 minutes at 4◦C. Af-
ter incubation, the cells were washed twice and fixed in
0.4 mL of 2% paraformaldehyde, and then analyzed with
a Partec Pas flow cytometer (Partec, Munster, Germany)
and Partec FloMax software.
PAI-1 promoter/luciferase plasmid
(pGL2PAI-1.1.5) construction
To demonstrate that thrombin effect on PAI-1 gene
expression was at the transcriptional level, 1.5 kb of the
PAI-1 5′-flanking region was subcloned into pGL2-Basic
luciferase vector (Promega, Madison, WI, USA). To facil-
itate subcloning, both forward and reverse primers con-
tained two different restriction sites (Forward 5′-CTTAA
CGCTAGCTCTCCCATCACCCCTAGATG-3′ con-
taining the NheI restriction site; reverse 5′-TTCATC
AGATCTAGGAATAGCGGGGGATCAT-3′ contain-
ing the BglII site). The PAI-1 promoter region was first
synthesized by PCR (95◦C 10’; 94◦C 1′, 60◦C 1′, 72◦C 1′,
35 cycles; 72◦C 7′). Products from PCR were digested
with NheI and BglII and subcloned into pGL2-Basic
linearized with the same enzymes. Orientation and
identification were confirmed by DNA sequencing (data
not shown).
Transient transfections and luciferase assay
To evaluate the modulation of AP-1 activity induced
by thrombin and PMA, and to investigate the direct ef-
fect of thrombin on PAI-1 gene trascription, we tran-
siently transfected HK2 and PTEC with pLuc3XAP-1
and pGL2PAI-1.1.5, respectively. Transient transfection
was carried out by electroporation using the Gene Pulser
II RF module (Biorad, Hercules, CA, USA). Confluent
HK2 and PTEC cells were trypsinized, and 5 × 106 cells
were resuspended in half milliliter medium containing 7.5
lg of pLuc3XAP-1 and 2.5 lg of pCMVbGal and kept on
ice for 5 minutes. Electroporation was carried out at 50
lF and 1.2 Kv. After electroporation, cells were placed
on ice for 5 minutes and then plated in a 6-well plate at
a concentration of 8 × 105/well. At 24 hours the medium
was removed, 2 mL of fresh medium were added, and
incubation continued for 24 hours. To determine the ef-
fect of thrombin and PMA stimulation, the cells were
rinsed once with DMEM/F12, and triplicate wells were
incubated with or without human thrombin (5 U/mL) or
PMA (20 ng/mL) in the presence or in the absence of spe-
cific inhibitors [PMA (100 nmol/L) for 48 hours, curcumin
(8 lmol/L) for 18 hours, PP1 (50 lmol/L) for 18 hours],
in 1 mL of serum-free DMEM/F12. Following incubation
for the indicated time periods, the cells were rinsed once
in PBS, then scraped and lysed in 100 lL of reporter lysis
buffer supplied with the Luciferase Reporter Assay Sys-
tem (Promega). The extracts were incubated at RT for
10 minutes and centrifuged at 12,000g for 5 minutes.
Twenty microliters of the supernatant were assayed for
luciferase activity using a DIGENE DCR-1 luminome-
ter (Abbott Laboratories, Abbott Park, IL, USA). Lu-
ciferase activity was normalized to b-galactosidase.
RNA isolation and Northern blot analysis
HK2 cells were plated in 60-mm2 Petri dishes and cul-
tured as detailed above. After reaching confluence, cells
were serum-starved for 40 hours and then incubated for
the indicated time periods with thrombin (5 U/mL). In
separate sets of experiments, cells were preincubated with
curcumin (8 lmol/L), PP1 (50 lmol/L), PP3 (50 lmol/L),
SP600125 (0.1 lmol/L), and H7 (50 lmol/L) for 18 hours
before adding thrombin or coincubated with actinomycin
D (2 lg/mL). At the end of incubation, cells were lysed
with 1 mL TRIzol Reagent (Life Technologies), and RNA
was isolated by the single-step method, using phenol and
chloroform/isoamylalcohol.
PAI-1 and u-PA gene expression was studied by
Northern blotting as previously described [10]. Briefly,
electrophoresis of 20 lg of total RNA from each ex-
perimental condition was carried out in 1.1% agarose
gel with 2.2 mol/L formaldehyde. The RNA was
then transferred overnight onto a nylon membrane
(Schleicher & Schuell, Dassel, Germany). The membrane
was stained with ethidium bromide to evaluate the 28S
and 18S ribosomal bands, and prehybridized at 42◦C for
4 hours in 50% formamide, 0.5% SDS, 5× SSC, and
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Fig. 1. Thrombin- (A, B) and phorbol 12-
myristate 13-acetate (PMA)-induced (C, D)
jun-N-terminal kinase (JNK) phosphoryla-
tion in proximal tubular cell line (HK2). Con-
fluent, quiescent HK2 cells were stimulated
with thrombin (5 U/mL) for 5, 15, and 30
minutes, or PMA (20 ng/mL) for 15 and
30 minutes and then lysed in RIPA buffer.
Equal amounts of protein from each cell lysate
(40 lg) were separated by sodium dodecyl
sulfate-polyacrylamide gel electrophoresis
(SDS-PAGE), transferred onto nitrocellu-
lose filter, and probed with mouse mon-
oclonal anti-phospho-JNK antibody as de-
scribed in Methods (A and C, top panels). The
same membranes were then stripped and im-
munoblotted again with antihuman JNK poly-
clonal antibody (A and C, bottom panels). The
figure is representative of three experiments.
Intensity of specific p-JNK bands was quanti-
fied by computer-assisted densitometry (Op-
tilab 2.6.1), normalized to the intensity of total
JNK bands, and expressed as pJNK/total JNK
ratio (B and D, mean ± SD of three separate
experiments). ∗P < 0.001 vs. basal.
0.1 mg/mL salmon sperm DNA. A 1253-bp fragment of
the human PAI-1 and a 600-bp fragment of the human u-
PA cDNAs were used as probes. The DNA fragment was
labeled by random priming using a commercially avail-
able kit (Amersham) and [32P]dCTP (specific activity:
3000 Ci/mmol). The probe (106cpm/mL) was added to
10 mL of prehybridization solution, and the blots were
hybridized for 16 hours at 42◦C. The membranes were
then washed once in 2 × SSC at room temperature for
5 minutes, once in 2 × SSC 0.1% SDS at room tempera-
ture for 20 minutes, once in the same buffer at 55◦C for
30 minutes, and in 1× SSC, 0.1% SDS at 55◦C for another
30 minutes. After drying, membranes were exposed to a
Kodak X-OMAT film (Rochester, NY, USA) with inten-
sifying screens at −70◦C.
3H-thymidine incorporation
DNA synthesis was measured as the amount of
[methyl-3H]-thymidine incorporated into trichloroacetic
(TCA)-precipitable material as previously described [9].
Briefly, HK2 were plated in 24-well dishes at a density of
4 × 104 cells/well, grown to confluence, and starved by
placing them in serum-free medium for 40 hours. The cell
monolayer was then incubated with thrombin (5 U/mL)
for 24 hours at 37◦C. In separate sets of experiments, cells
were preincubated with PMA (100 nmol/L) for 48 hours
or with curcumin (8 lmol/L) for 18 hours before adding
thrombin. At the end of the incubation period, cells were
pulsed for 4 hours with 1.0 lCi/mL of 3H-thymidine.
The medium was then removed, the cells were washed
twice in ice-cold 5% TCA, and incubated in 5% TCA for
5 minutes. The monolayer was solubilized by adding
0.75 mL of 0.25 N NaOH in 0.1% SDS. Half-milliliter
aliquots were then neutralized and counted in scintilla-
tion fluid using a b-counter.
Statistical analysis
Data are presented as mean ± standard deviation (SD)
and compared by analysis of variance (ANOVA). A P <
0.05 was considered statistically significant.
RESULTS
We first investigated the effects of thrombin on JNK
activity in HK2 cells. To this purpose, we evaluated the
cellular levels of the active, phosphorylated form of the
enzyme by Western blotting using a specific antiphospho-
JNK antibody. Thrombin (5 U/mL) induced a striking
increase of JNK phosphorylation in quiescent HK2 cells
already after 5 minutes of incubation, and with a peak at
15 minutes (Fig. 1). Interestingly, direct PKC activation,
obtained by incubating HK2 cells with PMA (20 ng/mL),
also caused JNK phosphorylation, with the same time
pattern observed with thrombin (Fig. 1).
To evaluate the functional role of JNK on AP-1 ac-
tivation in this setting, we transfected HK2 cells with
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p3xAP-1Luc, an expression vector in which the reporter
gene (luciferase) is under the control of three AP-1 con-
sensus sequences [26]. Both thrombin (basal 100 ± 13;
thrombin 8 hours 498 ± 55; 24 hours 404 ± 59; 48 hours
326 ± 45 luciferase activity,% of basal, P < 0.001) and
PMA (basal 100 ± 15; PMA 8 hours 168 ± 20; 24 hours
234 ± 35; 48 hours 248 ± 35, luciferase activity,% of basal,
P < 0.001) caused a striking increase in luciferase activ-
ity in a time-dependent manner. In addition, both PKC
down-regulation, obtained by prolonged PMA preincu-
bation (basal 100 ± 18; thrombin 322 ± 38; PMA 48 hours
110 ± 20; thrombin + PMA 48 hours 118 ± 19, luciferase
activity,% of unstimulated, P < 0.001), and JNK inhibi-
tion, by curcumin (basal 100 ± 11; thrombin 908 ± 102;
curcumin + thrombin 151 ± 50; luciferase activity,% of
unstimulated, P < 0.001) significantly inhibited this cellu-
lar effect of thrombin. Because several reports described
an increased internalization of PAR-1 after PKC activa-
tion, we investigated the effect of prolonged exposure to
PMA on PAR-1 membrane expression to exclude that in-
hibitory effects of PMA could be caused by a decreased
number of receptors available for thrombin binding. Pro-
longed PKC activation did not significantly affect the
expression on the cell surface of the thrombin receptor
PAR-1, as demonstrated by flow cytometry analysis of
HK2 cells preincubated with PMA (100 nmol/L) for 48
hours (basal 87.5 ± 12.2% of positive cells, MFI 9.1 ± 1.4;
PMA 94.9 ± 16.1% of positive cells, MFI 7.8 ± 1.3).
To better define the signaling pathway linking PKC ac-
tivation to JNK phosphorylation, we focused our atten-
tion on src, a cytoplasmic tyrosine kinase. We previously
demonstrated the ability of thrombin to activate this ty-
rosine kinase in HK2 cells [15]. We investigated whether
direct PKC activation, obtained with PMA, may cause src
phosphorylation on tyrosine 418. The phosphorylation of
this tyrosine residue represents the specific activation sig-
nal for this cytoplamic kinase. Short-term PMA incuba-
tion caused a significant and time-dependent increase of
src Y418 phosphorylation, with a peak after 30 minutes of
incubation (Fig. 2). Preincubation of HK2 cells with a spe-
cific src inhibitor, PP1, significantly reduced both PMA-
(basal 100 ± 15; PMA 223 ± 29; PP1 100 ± 19; PP1 + PMA
97 ± 15, luciferase activity,% of basal, P < 0.001) and
thrombin-stimulated luciferase activity (basal 100 ± 12;
thrombin 236 ± 33; PP1 100 ± 15; PP1 + thrombin 112 ±
18, luciferase activity,% of basal, P < 0.001), whereas its
inactive analog, PP3, at the same molar concentration,
did not have any sort of effect (data not shown).
As in other renal cell lines [18], in HK2 cells thrombin
also induced a striking up-regulation of PAI-1 and u-PA
gene expression with a peak at 6 hours (Fig. 3A-C). These
thrombin effects were mimicked by incubation of HK2
cells with PMA with same time kinetics (Fig. 3D-F).
To demonstrate that the increase in PAI-1 mRNA lev-
els under thrombin stimulation was caused by an in-
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Fig. 2. Phorbol 12-myristate 13-acetate (PMA)-induced src phospho-
rylation in proximal tubular cell line (HK2). Confluent quiescent HK2
cells were stimulated with PMA (20 ng/mL) for 15, 30, and 60 min-
utes, and then lysed in RIPA buffer. Equal amounts of protein from
each cell lysate (40 lg) were separated by sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE), transferred onto ni-
trocellulose filter, and probed with rabbit polyclonal anti-phospho-
Y418-src antibody as described in Methods (A, top panel). The same
membranes were then stripped and immunoblotted again with anti-
human src polyclonal antibody (A, lower panel). The figure is repre-
sentative of three experiments. Intensity of specific p-src bands was
quantified by computer-assisted densitometry (Optilab 2.6.1), nor-
malized to the intensity of total c-src bands, and expressed as p-
src/total src ratio (B) (mean ± SD of three separate experiments).
∗P < 0.001 vs. basal.
creased gene transcription, we transfected HK2 cells with
an expression vector containing 1.5 kb of the PAI-1 5′-
flanking region (pGL2PAI-1.1.5); thrombin was able to
induce a significant increase in luciferase activity after 24
hours of stimulation (Fig. 4A). Moreover, coincubation
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Fig. 3. The effect of thrombin (A-C) and
phorbol 12-myristate 13-acetate (PMA)
(D-F) on plasminogen activator inhibitor-
1 (PAI-1) (A, B, D, E) and urokinase
plasminogen activator (u-PA) (A, C, D,
F) gene expression in human proximal
tubular cell line (HK2). Confluent, quiescent
HK2 cells were stimulated with thrombin
(5 U/mL) or incubated with PMA (20 ng/mL)
for 3, 6, and 24 hours, respectively, and then
harvested. PAI-1 and u-PA gene expression
was evaluated by Northern blotting (A, D,
upper and middle panels, respectively) as
described in Methods. 28S and 18S ribosomal
RNA bands on ethidium bromide–stained
gel were used to control the RNA loading
(A, D, lower panels). The figure is repre-
sentative of three experiments. Intensity
of specific mRNA bands was quantified by
computer-assisted densitometry (Optilab
2.6.1), normalized to the intensity of the 28S
bands on the ethidium bromide–stained blots,
and expressed as PAI-1/28S ratio (B and E)
(mean ± SD of three separate experiments)
and u-PA/28S ratio (C and F) (mean ± SD
of three separate experiments), respectively.
∗P < 0.001 vs. basal.
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Fig. 4. Thrombin-induced plasminogen acti-
vator inhibitor-1 (PAI-1) promoter activity in
proximal tubular cell line (HK2) (A). Con-
fluent HK2 cells were trypsinized and 5 ×
106 cells were resuspended in half milliliter
medium containing 7.5 lg of pGL2PAI-1.1.5
and 2.5 lg of pCMVbGal. Electroporation
was carried out as described in Methods.
Transfected cells were incubated with or with-
out human thrombin (5 U/mL) in serum-free
medium for 24 hours. Effect of actinomycin
D on thrombin-induced PAI-1 gene expres-
sion (B, C). Confluent, quiescent HK2 cells
were incubated with actinomycin D (2 lg/mL)
and thrombin (5 U/mL) for 2 hours, and then
harvested. PAI-1 gene expression was eval-
uated by Northern blotting (B, upper panel)
as described in Methods. 28S and 18S ri-
bosomal RNA bands on ethidium bromide–
stained gel were used to control the RNA
loading (B, lower panel). The figure is rep-
resentative of three experiments. Intensity
of specific mRNA bands was quantified by
computer-assisted densitometry, normalized
to the intensity of the 28S bands on the ethid-
ium bromide–stained blots, and expressed as
PAI-1/28S ratio (C) (mean ± SD of three sep-
arate experiments). ∗P < 0.001 vs. basal.
of HK2 cells with actinomycin D completely abolished
thrombin-induced PAI-1 gene expression (Fig. 4B-C).
Thrombin-elicited PAI-1 gene expression was
markedly inhibited by PKC down-regulation, obtained
either with prolonged PMA preincubation (Fig. 5A and
B) or with the specific inhibitor H7 (Fig. 5C and D).
Interestingly, preincubation with PP1, the specific src
inhibitor, significantly reduced both thrombin (Fig. 6A
and B) and PMA-induced PAI-1 gene expression (Fig. 6C
and D). In addition, curcumin, a specific JNK-AP-1
inhibitor [28], completely abolished PAI-1 gene ex-
pression induced by both thrombin (Fig. 7A and B)
and PMA (Fig. 7E-F). Another specific JNK inhibitor,
SP600125 [29], also confirmed the significant reduction
of thrombin-induced PAI-1 gene expression in HK2 cells
(Fig. 7C and D).
We then investigated whether thrombin induced u-PA
gene expression through the same signaling pathway. In-
terestingly, PKC down-regulation completely inhibited
thrombin-elicited u-PA gene expression (Fig. 8). On the
contrary, both PP1 preincubation and JNK inhibition by
curcumin did not influence the increase in u-PA mRNA
levels induced by the coagulation factor (Fig. 8).
We previously reported the powerful mitogenic effect
of thrombin in PTEC and the central role of src in this
event [9]. In order to investigate the role of JNK and
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Fig. 5. The effect of protein kinase C (PKC)
inhibition on thrombin-induced plasminogen
activator inhibitor-1 (PAI-1) gene expression
in proximal tubular cell line (HK2). Conflu-
ent, quiescent HK2 cells were preincubated
with phorbol 12-myristate 13-acetate (PMA)
(100 nmol/L) 48 hours, or H7 (50 lmol/L), re-
spectively, and then stimulated with thrombin
(5 U/mL) for 6 hours and harvested. PAI-1
expression was evaluated by Northern blot-
ting (A and C, upper panels) as described in
Methods. 28S and 18S ribosomal RNA bands
on ethidium bromide–stained gel were used to
control the RNA loading (A and C, lower pan-
els). The figure is representative of three ex-
periments. Intensity of specific mRNA bands
was quantified by computer-assisted densito-
metry (Optilab 2.6.1), normalized to the in-
tensity of the 28S bands on the ethidium
bromide–stained blots, and expressed as PAI-
1/28S ratio (B and D) (mean ± SD of three
separate experiments). ∗P < 0.001 vs. basal.
PKC activation in thrombin proliferative effect, we eval-
uated the influence of prolonged PMA preincubation
and JNK inhibition on thrombin-induced DNA synthe-
sis. Interestingly, PKC down-regulation (basal 910 ± 101;
thrombin 3480 ± 360; PMA + thrombin 1620 ± 180,
3H-tymidine incorporation, cpm/well, P < 0.001), but
not JNK inhibition (basal 1010 ± 120; thrombin 2453 ±
270; curcumin + thrombin 2558 ± 280; 3H-tymidine in-
corporation, cpm/well), caused a significant decrease in
thrombin-elicited thymidine uptake in HK2 cells.
DISCUSSION
The molecular mechanisms underlying the pathogen-
esis and progression of interstitial fibrosis in tubuloin-
terstitial injury are still largely unclear. Priming of the
coagulation cascade has been suggested as a potential
pivotal pathogenic event [5, 10, 18]. Thrombin, besides
its central role in the coagulation cascade, modulates
pleiotropic cell functions through the interaction with its
proteolytically activated receptor(s), and may regulate,
along with other coagulation proteases, cell activation
[9–11, 16]. The availability of these factors in the inter-
stitial microenvironment is suggested by the presence of
prominent fibrin deposits in this renal compartment in
several acute and chronic nephropaties [4, 5, 10]. We have
previously demonstrated that PTECs express PAR-1,
the main thrombin receptor, and its activation may lead
to an increased gene expression of several proinflam-
matory and profibrotic mediators, including monocyte
chemotactic protein-1 (MCP-1), PAI-1, and transforming
growth factor (TGF)-b [9, 10, 16]. In addition, we recently
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Fig. 6. The effect of src inhibition on
thrombin-induced (A, B) and phorbol 12-
myristate 13-acetate (PMA)-induced (C, D)
plasminogen activator inhibitor-1 (PAI-1)
gene expression in proximal tubular cell line
(HK2). Confluent, quiescent HK2 cells were
pretreated with a specific src inhibitor (PP1,
50 lmol/L) or its inactive analog, PP3 (50
lmol/L), for 18 hours, stimulated with throm-
bin (5 U/mL) or PMA (20 ng/mL) for 6
hours, and then harvested. PAI-1 expression
was evaluated by Northern blotting (A, C,
upper panel) as described in Methods. 28S
and 18S ribosomal RNA bands on ethidium
bromide–stained gel were used to control the
RNA loading (A, C, lower panel). The fig-
ure is representative of three experiments.
Intensity of specific mRNA bands was quanti-
fied by computer-assisted densitometry (Op-
tilab 2.6.1), normalized to the intensity of the
28S bands on the ethidium bromide–stained
blots, and expressed as PAI-1/28S ratio (B, D)
(mean ± SD of three separate experiments).
∗P < 0.001 vs. basal.
demonstrated that tubular PAR-1 gene expression
is strikingly up-regulated during chronic allograft
nephropathy, and directly and significantly correlated
with the degree of interstitial fibrosis [10]. Despite these
observations, the possible role of the coagulation pro-
teases in the activation of PTEC is still largely unclear,
as well as the intracellular pathways turned on by these
proteolytic enzymes. The cellular signaling events in this
setting may represent potential therapeutic targets to
prevent progressive tubulointerstitial injury. Indeed, it
may be easier to inhibit a cellular enzyme than to block
the proteolytic activity of one or more coagulation fac-
tor(s) protected by their natural and pharmacologic in-
hibitors within the fibrin clots. In addition, the same sig-
naling pathways may also be activated by other potential
pathogenic mediators of chronic tubulointerstitial dam-
age, including angiotensin II, another G protein–coupled
receptor agonist.
Thrombin can activate JNK in several cell lines, includ-
ing CCL39 fibroblasts, human platelets, Jurkat T cells,
and HepG2, although the mechanisms linking the het-
erotrimeric G protein with JNK are still poorly defined
[30–33]. In the present study, we demonstrated for the first
time that thrombin induces the activation of the JNK-AP-
1 axis in proximal tubular epithelial cells, and that this
cellular event is completely inhibited by chronic PMA
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Fig. 7. The effect of jun-N-terminal kinase
(JNK) inhibition on thrombin- and phor-
bol 12-myristate 13-acetate (PMA)-induced
plasminogen activator inhibitor-1 (PAI-1)
gene expression in proximal tubular cell line
(HK2). Confluent, quiescent HK2 cells were
pretreated with two specific JNK inhibitors:
curcumin (8 lmol/L) (A, B, E, F) for 18 hours,
and SP600125 0.1 lmol/L (C, D) for 1 hour, re-
spectively. Cells were stimulated with throm-
bin (5 U/mL) (A-D) or PMA (20 ng/mL)
(E-F) for 6 hours, and then harvested. PAI-1
expression was evaluated by Northern blot-
ting (A, C, E, upper panels) as described in
Methods. 28S and 18S ribosomal RNA bands
on ethidium bromide–stained gel were used to
control the RNA loading (A, C, E, lower pan-
els). The figure is representative of three ex-
periments. Intensity of specific mRNA bands
was quantified by computer-assisted densito-
metry (Optilab 2.6.1), normalized to the in-
tensity of the 28S bands on the ethidium
bromide–stained blots, and expressed as PAI-
1/28S ratio (B, D, F) (mean ± SD of three
separate experiments). ∗P < 0.001 vs. basal.
stimulation and subsequent PKC down-regulation, with-
out affecting PAR-1 cell surface expression. In addition,
direct PKC activation could induce the phosphorylation
of JNK and the activation of the nuclear factor AP-1.
These results suggest that a phorbol ester–sensitive PKC
may be involved in the thrombin-induced JNK activation.
Interestingly, we observed that the activation of AP-1
induced by both thrombin and PMA was completely abol-
ished by preincubation with PP1, a powerful and selective
src inhibitor. Furthermore, we demonstrated that direct
PKC activation by PMA can stimulate src family kinase
activity. Thus, it is conceivable that src may represent the
link between PKC and JNK. Indeed, PKC is known to
interact with src and modulate its tyrosine kinase ac-
tivity. Gould et al [34] reported the ability of PKC to
phosphorylate src. Moyers et al [35] observed that PKC-
induced serine phosphorylation of src was able to influ-
ence the cellular responses to beta-adrenergic agonists,
soluble mediators interacting with G protein–coupled re-
ceptors. Recently, two specific PKC isoforms, delta and
epsilon, were shown to physically interact with src, and
to modulate its activity in different cell lines [36–37].
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Fig. 8. The effect of protein kinase C (PKC), src, and jun-N-terminal
kinase (JNK) inhibition on thrombin-induced urokinase plasminogen
activator (u-PA) gene expression. Confluent, quiescent HK2 cells were
pretreated with the specific src inhibitor PP1 (50 lmol/L), with the spe-
cific PKC inhibitor phorbol 12-myristate 13-acetate (PMA) (100 nmol/
mL), and with the specific JNK inhibitor curcumin (8 lmol/L) for
18 hours, stimulated with thrombin (5 U/mL) for 6 hours, and then
harvested. u-PA gene expression was evaluated by Northern blotting
(A, upper panel) as described in Methods. 28S and 18S ribosomal RNA
bands on ethidium bromide–stained gel were used to control the RNA
loading (A, lower panel). The figure is representative of three experi-
ments. Intensity of specific mRNA bands was quantified by computer-
assisted densitometry (Optilab 2.6.1), normalized to the intensity of the
28S bands on the ethidium bromide–stained blots, and expressed as
PAI-1/28S ratio (B) (mean ± SD of three separate experiments). ∗P <
0.001 vs. basal.
However, Rodriguez et al [38] reported that PKC inhibi-
tion did not influence bombesin- and bradikinin-induced
src activation, suggesting that PKC-dependent src acti-
vation is not induced by any G protein–coupled recep-
tor. The influence of src on JNK activity, on the other
hand, is well established. Indeed, Tateno et al [39] clearly
demonstrated in Drosophila that src lies upstream of
JNK in the signaling pathway, leading to epidermal clo-
sure. In addition, several authors demonstrated that src
plays a key role in JNK activation induced by oxidative
stress and heterotrimeric G-protein activation [40, 41].
However, Schmitz et al [24] reported that angiotensin
II–induced JNK activation in vascular smooth muscle
cells was src-independent, again suggesting an agonist-
specific signaling among G protein–coupled receptor
ligands.
Based on our data, we can consider the PKC-src-JNK-
AP-1 axis as the main thrombin-induced signaling path-
way in HK2 cells. However, the functional role of this
pathway on the different thrombin-induced cellular ef-
fects relevant for acute and chronic tubulointerstitial dis-
eases is still largely unclear. In this perspective, we have to
consider a potential beneficial effect represented by the
regenerative action of the serine protease on HK2 cells.
On the contrary, the increased PAI-1 gene expression
can represent a potentially detrimental effect. Indeed,
PAI-1 is dramatically up-regulated in a variety of fibrotic
disease, including chronic allograft nephropathy, and its
inhibition of plasmin generation induced by plasmino-
gen activators may significantly reduce the physiologic
degradation of several extracellular matrix components
[4, 5, 10]. In this scenario, the balance between PAI-1 and
u-PA, the main plasminogen-activator produced by
PTEC, may play a pivotal role in interstitial fibrosis. Sev-
eral reports suggest that thrombin may regulate both
PAI-1 and u-PA expression in different cell lines [21, 42].
However, in most of the cases, the net result of thrombin
effect is to reduce the cellular ability to activate plas-
minogen. In the present study, we suggest that the mod-
ulation of PAI-1 and u-PA gene expression is regulated
through divergent signaling pathways, thus suggesting the
possibility to pharmacologically influence the altered fib-
rinolytic balance.
There are several observations in different cell types
that u-PA gene expression induced by proinflammatory
cytokines or cellular stress is mainly dependent upon
AP-1 activation [43, 44]. However, there are also reports
that this gene could be induced by alternative pathways,
primarily involving NF-jB [45]. In most of the cases, how-
ever, previous studies focused on the role of u-PA in
the metastatic processes, and thus, dealt with tumor cell
lines. In addition, in our study we considered for the first
time the role of AP-1 in thrombin-induced u-PA gene
expression in tubular cells. The activation of PAR-1 by
this coagulation factor leads to the activation of signaling
pathways completely different by the agonists previously
studied, including tumor necrosis factor (TNF)-alpha and
interleukin (IL)-1, making any possible comparison even
more difficult.
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Fig. 9. Schematic representation of
thrombin-induced signaling pathways lead-
ing to mitogenesis, plasminogen activator
inhibitor-1 (PAI-1), and urokinase plasmino-
gen activator (u-PA) gene expression.
CONCLUSION
According to our observation, the PKC-src-JNK-AP-1
axis may represent the main signaling pathway activated
by thrombin in tubular epithelial cells. Interestingly, sev-
eral cellular effects of this serine protease depend upon
one or more of the signaling enzymes along this path-
way (Fig. 9). Indeed, the up-regulation of u-PA gene
expression, and thus, the potential fibrinolytic effect is
PKC-dependent but src and JNK independent. On the
other hand, the proliferative action depends upon both
PKC and src, but is not modulated by JNK. Finally, the
profibrotic effects require the whole PKC-src-JNK-AP-1
axis. These findings may suggest a possible therapeutic
approach to reduce the profibrotic effect of thombin and
potentiate its fibrinolytic and regenerative action in acute
and chronic tubulointerstitial injury.
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